@iah do better. parking exit is backed up to the 5th floor again. The decision to close another terminal shows terrible planning and no respect for travelers.
@XfinitySupport We haven’t heard anything about when service will be restored after the hurricane. It is impossible to contact a live person at xfinity. Some
people in my neighborhood have wifi but no one on our street with xfinity have wifi. When will we have wifi restored?
@CVSHealth been waiting for my sons Covid results for 5 days and there is no contact information so I can find out when his results will be available. Help!
Attending #ASH21 in person? If so, please be sure to visit our booth #2600 Sat - Mon in the exhibit hall at the Georgia World Congress Center to learn more about TG's research focus. Open Sat 11am – 5pm ET #CLL $TGTX #FearlessForPatients@ASH_Hematology
September is Blood Cancer Awareness Month! The TG Therapeutics team will be raising awareness throughout the month by sponsoring events and sharing facts about blood cancer. Join us to help #CancelBloodCancer $TGTX #FearlessForPatients
Available Now: Dr. Cheah's presentation at #ASCO21 evaluating TG-1701, a novel BTK inhibitor, in development as a monotherapy, and as a triple therapy with the investigational U2 combination. Watch: https://t.co/rLoQjYPwoO
TG is proud to support the LLS Virtual Rocky Mountain Blood Cancer Conference happening today, April 24th at 9:30 AM MT. This is an educational event for blood cancer patients, survivors & family members. Free registration: https://t.co/dnMaWzV7Qy @LLSusa $TGTX #FightBloodCancer
——-> From transfer to LSA
——-> To TAPPS 1st Team All-District
——-> To college football commit
Hit the link below to read senior LB Michael Purdom’s journey to becoming a college athlete from LSA
#SouthPride@Michael_Purdom@SUPiratesFB
Link: https://t.co/kBVZJZbyJx
We’ve completed our rolling submission of a BLA to the @US_FDA for ublituximab in combination with UKONIQ (umbralisib) as a treatment for patients with CLL! #MajorMilestone taking us closer to providing the U2 regimen to patients - Details: https://t.co/ETskYSk1bq $TGTX
DYK: ~1 million people are living with #MS in the US & ~2.3 million worldwide? In honor of #MultipleSclerosisAwareness week we honor all of those living with and taking care of someone with MS #ThisIsMS $TGTX
#Breaking: The @US_FDA has granted accelerated approval of our new therapy for relapsed/refractory #MZL & #FL! Our first oncology approval is a historic day for our patients, medical partners and the $TGTX Team. #FearlessforScience Learn more: https://t.co/xAIxqhLBrA